世界の事前医療市場は、2025年に百万米ドルと算定されており、2026年には百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）で推移し、2032年には百万米ドルに達すると予測されています。

事前医療の市場規模、推定値、予測値は売上収益で提示され、2025年を基準年とし、2021年から2032年までの過去データと予測データを含みます。本レポートは定量的・定性的分析を組み合わせ、企業が成長戦略の策定、競争環境の評価、現在の市場における自社の位置付けの分析、事前医療に関する情報に基づいたビジネス判断を行うことを支援します。
報告対象範囲
売上高予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
ADvault
VyncaCare
WiserCareInc
Sharp HealthCare
ACP Decisions
lris
Healthcare
Bronson Health Care Group
Koda Health
ThroughCare
Vital Decisions
Affirm Health
MIDEO
New Century Health
Thanacare
Island Health
Honor My Decisions LLC


タイプ別
Software
Service


用途別
Child
Adult


地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
グローバル事前医療市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、およびプレイヤー別の市場規模も提供されます。より深い洞察を得るため、本レポートでは競争環境、主要競合他社、それぞれの市場順位を分析し、技術動向や新製品開発について論じております。
本レポートの構成
第1章：事前医療市場の調査範囲および各市場セグメント（タイプ別、用途別など）のエグゼクティブサマリーを紹介いたします。市場規模や将来の発展可能性を含め、現状ならびに短期・中期・長期の動向について概観を提供いたします
第2章：事前医療の世界市場規模および地域別市場規模の概要を提示いたします。あわせて、市場トレンド、最新動向、成長を促進する要因と抑制要因、業界企業が直面する課題・リスク、関連政策について分析いたします
第3章：事前医療市場における企業の競争環境、収益シェア、最新の事業計画、合併・買収（M&A）情報などを詳細に分析いたします
第4章：事前医療市場をタイプ別に分類し、各セグメントの市場規模および成長余地を提示いたします
第5章：事前医療市場を用途別に整理し、各セグメントの市場規模および拡大可能性を明らかにいたします
第6章～第10章：事前医療市場について、北米、欧州、アジア太平洋、中南米、中東・アフリカを対象に国別分析を実施いたします。各地域および主要国の市場規模、発展可能性、生産能力、市場の成熟度、将来見通しを定量的に評価いたします
第11章：事前医療市場の主要プレイヤーの企業プロファイルを提供いたします。収益、粗利益率、製品ポートフォリオ、最近の事業展開などを網羅的に整理いたします
第12章：事前医療市場に関する重要な知見を総括し、結論を提示いたします
第13章：付録（調査方法論）

The global Advance Directives market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Advance Directives is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Advance Directives is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Advance Directives in Child is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Advance Directives include ADvault, VyncaCare, WiserCareInc, Sharp HealthCare, ACP Decisions, lris, Healthcare, Bronson Health Care Group, Koda Health, ThroughCare, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Advance Directives market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Advance Directives. The Advance Directives market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Advance Directives market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Advance Directives manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
ADvault
VyncaCare
WiserCareInc
Sharp HealthCare
ACP Decisions
lris
Healthcare
Bronson Health Care Group
Koda Health
ThroughCare
Vital Decisions
Affirm Health
MIDEO
New Century Health
Thanacare
Island Health
Honor My Decisions LLC

Segment by Type
Software
Service

Segment by Application
Child
Adult

By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Advance Directives companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advance Directives Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Software
1.2.3 Service
1.3 Market by Application
1.3.1 Global Advance Directives Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Advance Directives Market Perspective (2021–2032)
2.2 Global Advance Directives Growth Trends by Region
2.2.1 Global Advance Directives Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Advance Directives Historic Market Size by Region (2021–2026)
2.2.3 Advance Directives Forecasted Market Size by Region (2027–2032)
2.3 Advance Directives Market Dynamics
2.3.1 Advance Directives Industry Trends
2.3.2 Advance Directives Market Drivers
2.3.3 Advance Directives Market Challenges
2.3.4 Advance Directives Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Advance Directives Players by Revenue
3.1.1 Global Top Advance Directives Players by Revenue (2021–2026)
3.1.2 Global Advance Directives Revenue Market Share by Players (2021–2026)
3.2 Global Top Advance Directives Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Advance Directives Revenue
3.4 Global Advance Directives Market Concentration Ratio
3.4.1 Global Advance Directives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advance Directives Revenue in 2025
3.5 Global Key Players of Advance Directives Head Offices and Areas Served
3.6 Global Key Players of Advance Directives, Products and Applications
3.7 Global Key Players of Advance Directives, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans

4 Advance Directives Breakdown Data by Type
4.1 Global Advance Directives Historic Market Size by Type (2021–2026)
4.2 Global Advance Directives Forecasted Market Size by Type (2027–2032)

5 Advance Directives Breakdown Data by Application
5.1 Global Advance Directives Historic Market Size by Application (2021–2026)
5.2 Global Advance Directives Forecasted Market Size by Application (2027–2032)

6 North America
6.1 North America Advance Directives Market Size (2021–2032)
6.2 North America Advance Directives Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Advance Directives Market Size by Country (2021–2026)
6.4 North America Advance Directives Market Size by Country (2027–2032)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Advance Directives Market Size (2021–2032)
7.2 Europe Advance Directives Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Advance Directives Market Size by Country (2021–2026)
7.4 Europe Advance Directives Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland

8 Asia-Pacific
8.1 Asia-Pacific Advance Directives Market Size (2021–2032)
8.2 Asia-Pacific Advance Directives Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Advance Directives Market Size by Region (2021–2026)
8.4 Asia-Pacific Advance Directives Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand

9 Latin America
9.1 Latin America Advance Directives Market Size (2021–2032)
9.2 Latin America Advance Directives Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Advance Directives Market Size by Country (2021–2026)
9.4 Latin America Advance Directives Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Advance Directives Market Size (2021–2032)
10.2 Middle East & Africa Advance Directives Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Advance Directives Market Size by Country (2021–2026)
10.4 Middle East & Africa Advance Directives Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 ADvault
11.1.1 ADvault Company Details
11.1.2 ADvault Business Overview
11.1.3 ADvault Advance Directives Introduction
11.1.4 ADvault Revenue in Advance Directives Business (2021–2026)
11.1.5 ADvault Recent Development
11.2 VyncaCare
11.2.1 VyncaCare Company Details
11.2.2 VyncaCare Business Overview
11.2.3 VyncaCare Advance Directives Introduction
11.2.4 VyncaCare Revenue in Advance Directives Business (2021–2026)
11.2.5 VyncaCare Recent Development
11.3 WiserCareInc
11.3.1 WiserCareInc Company Details
11.3.2 WiserCareInc Business Overview
11.3.3 WiserCareInc Advance Directives Introduction
11.3.4 WiserCareInc Revenue in Advance Directives Business (2021–2026)
11.3.5 WiserCareInc Recent Development
11.4 Sharp HealthCare
11.4.1 Sharp HealthCare Company Details
11.4.2 Sharp HealthCare Business Overview
11.4.3 Sharp HealthCare Advance Directives Introduction
11.4.4 Sharp HealthCare Revenue in Advance Directives Business (2021–2026)
11.4.5 Sharp HealthCare Recent Development
11.5 ACP Decisions
11.5.1 ACP Decisions Company Details
11.5.2 ACP Decisions Business Overview
11.5.3 ACP Decisions Advance Directives Introduction
11.5.4 ACP Decisions Revenue in Advance Directives Business (2021–2026)
11.5.5 ACP Decisions Recent Development
11.6 lris
11.6.1 lris Company Details
11.6.2 lris Business Overview
11.6.3 lris Advance Directives Introduction
11.6.4 lris Revenue in Advance Directives Business (2021–2026)
11.6.5 lris Recent Development
11.7 Healthcare
11.7.1 Healthcare Company Details
11.7.2 Healthcare Business Overview
11.7.3 Healthcare Advance Directives Introduction
11.7.4 Healthcare Revenue in Advance Directives Business (2021–2026)
11.7.5 Healthcare Recent Development
11.8 Bronson Health Care Group
11.8.1 Bronson Health Care Group Company Details
11.8.2 Bronson Health Care Group Business Overview
11.8.3 Bronson Health Care Group Advance Directives Introduction
11.8.4 Bronson Health Care Group Revenue in Advance Directives Business (2021–2026)
11.8.5 Bronson Health Care Group Recent Development
11.9 Koda Health
11.9.1 Koda Health Company Details
11.9.2 Koda Health Business Overview
11.9.3 Koda Health Advance Directives Introduction
11.9.4 Koda Health Revenue in Advance Directives Business (2021–2026)
11.9.5 Koda Health Recent Development
11.10 ThroughCare
11.10.1 ThroughCare Company Details
11.10.2 ThroughCare Business Overview
11.10.3 ThroughCare Advance Directives Introduction
11.10.4 ThroughCare Revenue in Advance Directives Business (2021–2026)
11.10.5 ThroughCare Recent Development
11.11 Vital Decisions
11.11.1 Vital Decisions Company Details
11.11.2 Vital Decisions Business Overview
11.11.3 Vital Decisions Advance Directives Introduction
11.11.4 Vital Decisions Revenue in Advance Directives Business (2021–2026)
11.11.5 Vital Decisions Recent Development
11.12 Affirm Health
11.12.1 Affirm Health Company Details
11.12.2 Affirm Health Business Overview
11.12.3 Affirm Health Advance Directives Introduction
11.12.4 Affirm Health Revenue in Advance Directives Business (2021–2026)
11.12.5 Affirm Health Recent Development
11.13 MIDEO
11.13.1 MIDEO Company Details
11.13.2 MIDEO Business Overview
11.13.3 MIDEO Advance Directives Introduction
11.13.4 MIDEO Revenue in Advance Directives Business (2021–2026)
11.13.5 MIDEO Recent Development
11.14 New Century Health
11.14.1 New Century Health Company Details
11.14.2 New Century Health Business Overview
11.14.3 New Century Health Advance Directives Introduction
11.14.4 New Century Health Revenue in Advance Directives Business (2021–2026)
11.14.5 New Century Health Recent Development
11.15 Thanacare
11.15.1 Thanacare Company Details
11.15.2 Thanacare Business Overview
11.15.3 Thanacare Advance Directives Introduction
11.15.4 Thanacare Revenue in Advance Directives Business (2021–2026)
11.15.5 Thanacare Recent Development
11.16 Island Health
11.16.1 Island Health Company Details
11.16.2 Island Health Business Overview
11.16.3 Island Health Advance Directives Introduction
11.16.4 Island Health Revenue in Advance Directives Business (2021–2026)
11.16.5 Island Health Recent Development
11.17 Honor My Decisions LLC
11.17.1 Honor My Decisions LLC Company Details
11.17.2 Honor My Decisions LLC Business Overview
11.17.3 Honor My Decisions LLC Advance Directives Introduction
11.17.4 Honor My Decisions LLC Revenue in Advance Directives Business (2021–2026)
11.17.5 Honor My Decisions LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer